Plexus (PLXS) Expected to Announce Quarterly Earnings on Wednesday

Plexus (NASDAQ:PLXS) is expected to be announcing its Q2 2025 earnings results after the market closes on Wednesday, April 23rd. Analysts expect Plexus to post earnings of $1.54 per share and revenue of $980.07 million for the quarter. Plexus has set its Q2 2025 guidance at 1.460-1.610 EPS.

Plexus (NASDAQ:PLXS) last announced its earnings results on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. On average, analysts expect Plexus to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Plexus Stock Performance

Shares of PLXS stock opened at $121.02 on Tuesday. The stock’s 50-day moving average price is $126.81 and its 200 day moving average price is $144.52. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $3.27 billion, a PE ratio of 28.08 and a beta of 0.83. Plexus has a 52-week low of $93.58 and a 52-week high of $172.89.

Insider Activity at Plexus

In other news, CFO Patrick John Jermain sold 3,361 shares of Plexus stock in a transaction on Monday, January 27th. The stock was sold at an average price of $144.57, for a total transaction of $485,899.77. Following the completion of the transaction, the chief financial officer now owns 20,745 shares of the company’s stock, valued at $2,999,104.65. The trade was a 13.94 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Randy J. Martinez sold 887 shares of the stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $140.52, for a total transaction of $124,641.24. Following the completion of the sale, the director now directly owns 4,831 shares in the company, valued at approximately $678,852.12. The trade was a 15.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 17,958 shares of company stock worth $2,551,930 over the last 90 days. Company insiders own 1.76% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Benchmark reaffirmed a “buy” rating and set a $165.00 price target on shares of Plexus in a report on Wednesday, January 22nd. Needham & Company LLC lifted their target price on shares of Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a report on Friday, January 24th. Finally, Stifel Nicolaus began coverage on shares of Plexus in a research report on Tuesday, February 4th. They issued a “hold” rating and a $152.00 price objective for the company. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Plexus has an average rating of “Moderate Buy” and an average target price of $163.00.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.